FibroBiologics Inc (FBLG)
2.60
+0.19
(+7.88%)
USD |
NASDAQ |
Nov 22, 16:00
2.59
-0.01
(-0.38%)
After-Hours: 20:00
FibroBiologics Shareholders Equity (Quarterly): 2.737M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.737M |
| June 30, 2024 | -2.387M |
| March 31, 2024 | -3.863M |
| December 31, 2023 | 1.253M |
| Date | Value |
|---|---|
| September 30, 2023 | 10.54M |
| June 30, 2023 | 11.35M |
| December 31, 2022 | -3.996M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-3.996M
Minimum
Dec 2022
11.35M
Maximum
Jun 2023
2.234M
Average
1.253M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
| Charles River Laboratories International Inc | 3.782B |
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 2.912M |
| IGC Pharma Inc | 7.377M |
| NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.47M |
| Total Liabilities (Quarterly) | 7.732M |